Sequent Scientific [SEQUENT] vs RPG Life Sciences [RPGLIFE] Detailed Stock Comparison

Sequent Scientific Ltd.

NSE
Loading...

RPG Life Sciences Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sequent Scientific Ltd. wins in 4 metrics, RPG Life Sciences Ltd. wins in 14 metrics, with 1 ties. RPG Life Sciences Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sequent Scientific Ltd. RPG Life Sciences Ltd. Better
P/E Ratio (TTM) 123.42 16.43 RPG Life Sciences Ltd.
Price-to-Book Ratio 6.21 6.01 RPG Life Sciences Ltd.
Debt-to-Equity Ratio 55.31 0.00 Tie
PEG Ratio 0.23 0.04 RPG Life Sciences Ltd.
EV/EBITDA 30.04 21.00 RPG Life Sciences Ltd.
Profit Margin (TTM) 2.52% 30.08% RPG Life Sciences Ltd.
Operating Margin (TTM) 9.66% 19.10% RPG Life Sciences Ltd.
EBITDA Margin (TTM) 9.66% 19.10% RPG Life Sciences Ltd.
Return on Equity 6.64% 34.54% RPG Life Sciences Ltd.
Return on Assets (TTM) 4.91% 27.86% RPG Life Sciences Ltd.
Free Cash Flow (TTM) $442.73M $418.30M Sequent Scientific Ltd.
Dividend Yield N/A 1.50% N/A
1-Year Return 26.71% -5.33% Sequent Scientific Ltd.
Price-to-Sales Ratio (TTM) 5.29 4.94 RPG Life Sciences Ltd.
Enterprise Value $55.23B $30.27B Sequent Scientific Ltd.
EV/Revenue Ratio 3.33 4.49 Sequent Scientific Ltd.
Gross Profit Margin (TTM) 54.46% 63.95% RPG Life Sciences Ltd.
Revenue per Share (TTM) $66 $407 RPG Life Sciences Ltd.
Earnings per Share (Diluted) $1.63 $122.43 RPG Life Sciences Ltd.
Beta (Stock Volatility) 0.96 -0.39 RPG Life Sciences Ltd.

Sequent Scientific Ltd. vs RPG Life Sciences Ltd. Stock Performance Analysis

Loading Price Chart...

SEQUENT
RPGLIFE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sequent Scientific Ltd.0.54%-0.20%11.92%29.09%19.28%20.60%
RPG Life Sciences Ltd.3.65%9.99%0.23%21.27%-3.07%-0.65%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sequent Scientific Ltd.26.71%229.31%-7.05%107.29%69.54%69.54%
RPG Life Sciences Ltd.-5.33%141.37%397.35%866.94%2,586.91%2,227.24%

Performance & Financial Health Analysis: Sequent Scientific Ltd. vs RPG Life Sciences Ltd.

MetricSEQUENTRPGLIFE
Market Information
Market Cap i₹84.41B₹33.63B
Market Cap CategoryMid capSmall cap
10 Day Avg. Volume i762,00420,221
90 Day Avg. Volume i791,56712,783
Last Close₹251.30₹2,297.70
52 Week Range₹166.00 - ₹277.35₹1,733.00 - ₹2,725.00
% from 52W High-9.39%-15.68%
All-Time High₹336.50 (Jun 28, 2021)₹2,974.95 (Oct 14, 2024)
% from All-Time High-25.32%-22.77%
Growth Metrics
Quarterly Revenue Growth0.15%0.04%
Quarterly Earnings Growth4.65%-0.37%
Financial Health
Profit Margin (TTM) i0.03%0.30%
Operating Margin (TTM) i0.10%0.19%
Return on Equity (TTM) i0.07%0.35%
Debt to Equity (MRQ) i55.310.00
Cash & Liquidity
Book Value per Share (MRQ)₹32.38₹334.93
Cash per Share (MRQ)₹2.84₹135.14
Operating Cash Flow (TTM) i₹1.04B₹1.08B
Levered Free Cash Flow (TTM) i₹-14,897,500₹1.83B
Dividends
Last 12-Month Dividend Yield iN/A1.50%
Last 12-Month Dividend i₹0.00₹36.00

Valuation & Enterprise Metrics Analysis: Sequent Scientific Ltd. vs RPG Life Sciences Ltd.

MetricSEQUENT (Mar 28, 2026)RPGLIFE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i123.4216.43
Forward P/E i39.8470.38
PEG Ratio i0.230.04
Price to Sales (TTM) i5.294.94
Price to Book (MRQ) i6.216.01
Market Capitalization
Market Capitalization i₹84.41B₹33.63B
Enterprise Value i₹55.23B₹30.27B
Enterprise Value Metrics
Enterprise to Revenue i3.334.49
Enterprise to EBITDA i30.0421.00
Risk & Other Metrics
Beta i0.96-0.39
Book Value per Share (MRQ) i₹32.38₹334.93

Financial Statements Comparison: Sequent Scientific Ltd. vs RPG Life Sciences Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSEQUENT (2025)RPGLIFE (2025)
Revenue/Sales i15.47B6.48B
Cost of Goods Sold i8.64B2.24B
COGS % of Revenue i55.9%34.6%
Gross Profit i6.83B4.24B
Gross Margin i44.1%65.4%
Research & Development iN/AN/A
Operating Income (EBIT) i1.19B1.40B
Operating Margin i7.7%21.7%
EBITDA i1.63B1.64B
EBITDA Margin i10.5%25.4%
Pre-Tax Income i443.06M2.33B
Pre-Tax Income % of Revenue i2.9%36.0%
Income Tax i120.47M496.40M
Income Tax % of Revenue i0.8%7.7%
Net Income (Profit) i322.59M1.83B
Profit Margin i2.1%28.3%

Balance Sheet & Liquidity Metrics

MetricSEQUENT (2025)RPGLIFE (2025)
Cash & Equivalents i626.60M287.00M
Total Current Assets i8.74B4.65B
Total Current Assets % of Revenue i56.5%71.8%
Total Current Liabilities i5.05B1.20B
Total Current Liabilities % of Revenue i32.6%18.5%
Long-Term Debt i3.00BN/A
Long-Term Debt % of Revenue i19.4%0.0%
Total Shareholders Equity i7.70B5.31B
Retained Earnings i1.25B4.74B
Retained Earnings % of Revenue i8.1%73.2%
Property, Plant & Equipment i2.84B1.61B

Cash Flow Statement Comparison

MetricSEQUENT (2025)RPGLIFE (2025)
Operating Cash Flow i360.47M1.08B
Operating Cash Flow % of Revenue i2.3%16.7%
Capital Expenditures i-293.87M734.40M
Free Cash Flow i442.73M418.30M
FCF Margin i2.9%6.5%
Debt Repayment i-1.88B0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSEQUENTRPGLIFE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i435.72M16.54M
Float Shares i96.00M3.40M
% Held by Insiders i68.03%74.93%
% Held by Institutions i7.40%5.49%
% Held by Public i24.57%19.58%

Dividend Analysis & Yield Comparison: Sequent Scientific Ltd. vs RPG Life Sciences Ltd.

MetricSEQUENTRPGLIFE
Last 12-Month Dividend i₹0.00₹36.00
Last 12-Month Dividend Yield iN/A1.50%
3-Year Avg Annual Dividend i₹0.00₹19.20
3-Year Avg Dividend Yield iN/A1.17%
3-Year Total Dividends i₹0.00₹57.60
Ex-Dividend DateN/AJun 27, 2025